In advanced patients with PD, whose pharmacological options have been exhausted, or have drug-resistant freezing of gait and marked fluctuations, it would appear that AADC gene transfer would hold promise for restoring levodopa responsiveness. This evidence concerns the gene DDC and Parkinson disease.